Published 2 days ago • loading... • Updated 1 day ago
Calgary-developed wound treatment used on the battlefield in Ukraine
NanoSALV Catalytic can be flown by drone and used by minimally trained personnel, with 6,000 wounded soldiers and civilians treated so far, officials said.
On Wednesday, Calgary-based NanoTess announced at the CAN Health Network Annual Conference that its NanoSALV gel has treated 6,000 soldiers and civilians in Ukraine, delivered via drone to front-line units.
Initially funded by the Department of National Defence in 2020, the gel uses copper, titanium dioxide, and silica to fight infections and regenerate tissue. NanoTess has donated $600,000 worth to Ukraine since June.
Australian clinical pharmacist Hailie Uren of the Ukrainian Ministry of Health noted the gel allows wounds to heal "without consistent nursing intervention," critical where one nurse manages up to 90 patients.
Despite availability in 14,000 pharmacies domestically, Canadian adoption remains slow. CEO Megan Leslie cited the recent wildfire at Canadian Forces Base Wainwright, which killed four soldiers, as evidence of urgent mass casualty preparedness needs.
Although the gel was added to the Canadian Armed Forces procurement list six months ago, NanoTess has yet to see meaningful uptake. The company continues educating clinicians to improve Canada's readiness for mass casualty events.